Skip to content

Clinical trials

Phase 3 Bone Marrow Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Marrow Diseases Phase: Phase 3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20072
20112
20122
20131
20144
20152
20172
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AOP Orphan Pharmaceuticals AG2
Ariad Pharmaceuticals2
CTI BioPharma2
AO GENERIUM1
Amgen1
Il-Yang Pharm. Co., Ltd.1
Janssen-Cilag International NV1
Pfizer1
Sierra Oncology LLC - a GSK company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Marrow Diseases17
Hematologic Diseases13
Myeloproliferative Disorders9
Anemia6
Leukemia6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia, Myeloid6
Polycythemia Vera5
Primary Myelofibrosis4
Hematologic Neoplasms3

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.